Next Generation Sequencing-Based Identification of T-Cell Receptors for Immunotherapy Against Hepatocellular Carcinoma
基于下一代测序的 T 细胞受体鉴定用于肝细胞癌的免疫治疗
阅读:6
作者:Yipeng Ma, Jiayu Ou, Tong Lin, Lei Chen, Junhui Chen, Mingjun Wang
| 期刊: | Hepatology Communications | 影响因子: | 5.600 |
| 时间: | 2021 | 起止号: | 2021 Feb 28;5(6):1106-1119. |
| doi: | 10.1002/hep4.1697 | 研究方向: | 信号转导、肿瘤 |
| 疾病类型: | 肝癌 | 细胞类型: | T细胞 |
| 信号通路: | T Cell Receptor | |
Conclusion
Two pairing strategies, ranking-based strategy and α-β chain mixture-based strategy, have proved to be useful for NGS-based TCR identification, particularly for polyclonal T cells purified by a peptide-major histocompatibility complex (pMHC) multimer-based approach. Functional evaluation confirmed the specificity and avidity of two identified HBV-specific TCRs, which may potentially be used to produce TCR-T cells to treat patients with HBV-related HCC.
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。